LUBBOCK, TX —The FDA officially approved 20 ZYN nicotine pouch products for sale in the U.S. on Thursday, January 16. This will be the first time nicotine pouches have been given the green light for marketing in the U.S.
According to the FDA, the popular nicotine pouches meet the health standards set by the 2009 Family Smoking Prevention and Tobacco Control Act. The agency found that the pouches are less harmful than cigarettes and smokeless tobacco because they contain fewer dangerous chemicals.
Studies showed that many adults who smoked or used smokeless tobacco products switched to nicotine pouches. The FDA believes that this switch could offer a healthier alternative for smokers trying to quit.
“To receive marketing authorizations, the FDA must have sufficient evidence that the new products offer greater benefits to population health than risks,” said Dr. Matthew Farrelly, director of the Office of Science in the FDA’s Center for Tobacco Products. “In this case, the data show that these nicotine pouch products meet that bar by benefiting adults who use cigarettes and/or smokeless tobacco products and completely switch to these products.”
A recent survey showed that only 1.8% of middle and high school students use nicotine pouches compared to other tobacco products.
The 20 approved ZYN products come in these flavors: Chill, Cinnamon, Citrus, Coffee, Cool Mint, Menthol, Peppermint, Smooth, Spearmint, and Wintergreen, and are available in two nicotine strengths, 3mg and 6mg.
While the FDA has authorized these products for sale, it stresses that they are not considered “safe” and cannot claim to be less harmful unless further testing is done.
The FDA has officially approved ZYN nicotine pouches for marketing
(Credit: truthinitiative.org)
Subscribe to the LIVE! Daily
Required
Post a comment to this article here: